ATE241011T1 - Serin-reiche peptidlinker - Google Patents

Serin-reiche peptidlinker

Info

Publication number
ATE241011T1
ATE241011T1 AT92907232T AT92907232T ATE241011T1 AT E241011 T1 ATE241011 T1 AT E241011T1 AT 92907232 T AT92907232 T AT 92907232T AT 92907232 T AT92907232 T AT 92907232T AT E241011 T1 ATE241011 T1 AT E241011T1
Authority
AT
Austria
Prior art keywords
serine
peptide linkers
ser
rich peptide
domains
Prior art date
Application number
AT92907232T
Other languages
English (en)
Inventor
James S Huston
Hermann Oppermann
Serge N Timasheff
Original Assignee
Micromet Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micromet Ag filed Critical Micromet Ag
Application granted granted Critical
Publication of ATE241011T1 publication Critical patent/ATE241011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92907232T 1991-02-27 1992-02-27 Serin-reiche peptidlinker ATE241011T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66222691A 1991-02-27 1991-02-27
PCT/US1992/001478 WO1992015682A1 (en) 1991-02-27 1992-02-27 Serine-rich peptide linkers

Publications (1)

Publication Number Publication Date
ATE241011T1 true ATE241011T1 (de) 2003-06-15

Family

ID=24656899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907232T ATE241011T1 (de) 1991-02-27 1992-02-27 Serin-reiche peptidlinker

Country Status (9)

Country Link
EP (1) EP0573551B1 (de)
JP (1) JPH06508985A (de)
AT (1) ATE241011T1 (de)
AU (1) AU664030B2 (de)
CA (1) CA2100671C (de)
DE (1) DE69233068T2 (de)
DK (1) DK0573551T3 (de)
ES (1) ES2194838T3 (de)
WO (1) WO1992015682A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393438B1 (de) * 1989-04-21 2005-02-16 Amgen Inc. TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc A method of producing a recombinant human necrotic factor absorber
US6027725A (en) * 1991-11-25 2000-02-22 Enzon, Inc. Multivalent antigen-binding proteins
EP0625200B1 (de) * 1992-02-06 2005-05-11 Chiron Corporation Marker für krebs und biosynthetisches bindeprotein dafür
AU5670194A (en) * 1992-11-20 1994-06-22 Enzon, Inc. Linker for linked fusion polypeptides
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
PT1095141E (pt) * 1998-07-10 2006-07-31 Scios Inc Metodo para a producao de um peptido com um pi acima de 8 ou abaixo de 5
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
CA2544532C (en) 2003-11-28 2015-06-16 Micromet Ag Compositions comprising polypeptides
US7235641B2 (en) 2003-12-22 2007-06-26 Micromet Ag Bispecific antibodies
CA2662226C (en) 2006-09-10 2020-08-04 Glycotope Gmbh Fully human high yield production system for improved antibodies and proteins
EP1920782A1 (de) 2006-11-10 2008-05-14 Glycotope Gmbh Mikroorganismen oder deren Fraktionen fähig zur Aktivierung von Zelleimmunität gegen Kohlenhydrate
ATE548052T1 (de) 2008-01-17 2012-03-15 Philogen Spa Kombination aus einem anti-edb-fibronectin- antikörper-il-2-fusionsprotein und einem b-zellen bindenden molekül, b-zellen-vorläufern und/oder deren krebserregendem gegenspieler
EP2116555A1 (de) 2008-05-08 2009-11-11 Bayer Schering Pharma Aktiengesellschaft Verwendung eines spezifisch an ED-B Fibronectin bindenden radioaktiv markierten Moleküls bei einem Verfahren zur Behandlung von Hodgkin-Lymphom
WO2010059315A1 (en) 2008-11-18 2010-05-27 Merrimack Pharmaceuticals, Inc. Human serum albumin linkers and conjugates thereof
WO2011110490A1 (en) 2010-03-09 2011-09-15 Bayer Pharma Aktiengesellschaft Process for the production of radioactively labelled scfv antibody fragments, kits and compositions
SG191153A1 (en) 2010-12-23 2013-07-31 Hoffmann La Roche Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
CA2817448C (en) 2010-12-23 2019-01-22 F. Hoffmann-La Roche Ag Binding agent
WO2012085064A1 (en) 2010-12-23 2012-06-28 Roche Diagnostics Gmbh Detection of a posttranslationally modified polypeptide by a bi-valent binding agent
WO2012085069A2 (en) * 2010-12-23 2012-06-28 Roche Diagnostics Gmbh Detection of a polypeptide dimer by a bivalent binding agent
US9700610B2 (en) 2011-08-22 2017-07-11 Glycotope Gmbh Microorganisms carrying a tumor antigen
CN104039822A (zh) 2011-09-06 2014-09-10 诺沃—诺迪斯克有限公司 Glp-1衍生物
US20130344565A1 (en) * 2012-06-21 2013-12-26 Rapid Pathogen Screening, Inc. Optimization of Expression and Purification of Recombinant Human MxA Protein in E. Coli
WO2014036520A1 (en) 2012-08-30 2014-03-06 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-erbb3 agents
US11472876B2 (en) 2015-11-02 2022-10-18 Bioatla, Inc. Conditionally active polypeptides
CA3100608A1 (en) 2018-05-18 2019-11-21 Daiichi Sankyo Co., Ltd. Anti-muc1 antibody-drug conjugate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US831967A (en) * 1905-08-29 1906-09-25 Eugenie Mearis Table.
DK0489116T3 (da) * 1989-08-22 1994-05-02 Immunex Corp Fusionsproteiner omfattende GM-CSF og IL-3
EP0625200B1 (de) * 1992-02-06 2005-05-11 Chiron Corporation Marker für krebs und biosynthetisches bindeprotein dafür

Also Published As

Publication number Publication date
EP0573551B1 (de) 2003-05-21
ES2194838T3 (es) 2003-12-01
CA2100671A1 (en) 1992-08-28
EP0573551A4 (en) 1994-06-08
JPH06508985A (ja) 1994-10-13
AU664030B2 (en) 1995-11-02
DE69233068D1 (de) 2003-06-26
DK0573551T3 (da) 2003-08-04
CA2100671C (en) 1999-02-02
EP0573551A1 (de) 1993-12-15
WO1992015682A1 (en) 1992-09-17
AU1440392A (en) 1992-10-06
DE69233068T2 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
DK0573551T3 (da) Serinrige peptidlinkere
BR9812267B1 (pt) Hormônio de crescimento recombinante.
ES2176286T3 (es) Esteres de metido de pentapeptidos inhibidoras del cancer de seres humanos.
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
HU9501276D0 (en) Stabile, liophylised composition containing proteins
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
ATE154641T1 (de) Neues physiologisch aktives schweinepeptid (cnp- 53)
ES2084621T3 (es) Proteina biologicamente activa modificada.
ES2058479T3 (es) Compuestos peptidicos.
NO902871L (no) Fremgangsmaate for innfoering av et peptid i cytosol.
DK0478631T3 (da) Målsøgende midler
ES2087337T3 (es) Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos.
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
DE69002881D1 (de) Peptide und deren Benutzung.
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
GB2352518B (en) Screening of compunds for therapeutic activity
ES2094930T3 (es) Nueva proteina inhibidora de trombina aislada de garrapatas.
SE9101586D0 (sv) Modified thioredoxin and its use
DE3869939D1 (de) Biologisch wirksame peptide.
DE68901361D1 (de) Anorexigenische und hypotensive peptide.
GB8924416D0 (en) Sliding"pucker reducing"presser foot

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0573551

Country of ref document: EP